Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol‐associated disease etiology-Reference-Cited by-同舟云学术

Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol‐associated disease etiology

Published:2021-12-26 Issue: Volume: Page:
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur J Immunol

Author:

Weigand Kilian¹,Peschel Georg¹,Grimm Jonathan¹,Luu Khang²,Schacherer Doris¹,Wiest Reiner³,Müller Martina¹,Schwarz Herbert²^ORCID,Buechler Christa¹^ORCID

Affiliation:

1. Department of Internal Medicine I University Hospital Regensburg Regensburg Germany

2. Department of Physiology and Immunology Programme Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore

3. Department of Visceral Surgery and Medicine University Inselspital Bern Switzerland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149488

Reference71 articles.

1. Hepatitis C virus–T‐cell responses and viral escape mutations;Petrovic D.;Eur. J. Immunol.,2012

2. T cell immunity to hepatitis C virus: lessons for a prophylactic vaccine;Thimme R.;J. Hepatol.,2021

3. 4‐1BB as a therapeutic target for human disease;Lee S. W.;Adv. Exp. Med. Biol.,2009

4. The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention;Luu K.;J. Leukoc. Biol.,2020

5. CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction;Shao Z.;J. Leukoc. Biol.,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The levels of soluble CD137 are increased in tuberculosis patients and associated with disease severity and prognosis;European Journal of Immunology;2024-06-25

2. Soluble CD137: A Potential Prognostic Biomarker in Critically Ill Patients;International Journal of Molecular Sciences;2023-12-15

3. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients;Biomedicine & Pharmacotherapy;2023-08

4. Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis;Journal of Hepatocellular Carcinoma;2023-05

5. Soluble CD137 and risk of hepatocellular carcinoma: nested case–control studies in cohorts in Shanghai and Singapore;British Journal of Cancer;2023-03-28